PL2588460T3 - Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych - Google Patents

Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych

Info

Publication number
PL2588460T3
PL2588460T3 PL11804008T PL11804008T PL2588460T3 PL 2588460 T3 PL2588460 T3 PL 2588460T3 PL 11804008 T PL11804008 T PL 11804008T PL 11804008 T PL11804008 T PL 11804008T PL 2588460 T3 PL2588460 T3 PL 2588460T3
Authority
PL
Poland
Prior art keywords
solfonyloxybenzylamines
substituted
related compounds
cosmetic use
cosmetic
Prior art date
Application number
PL11804008T
Other languages
English (en)
Inventor
Dmitri S. Ptchelintsev
John W. Lyga
Russell Wyborski
Qian Zheng
Cheng S. Hwang
Original Assignee
Avon Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Products, Inc. filed Critical Avon Products, Inc.
Publication of PL2588460T3 publication Critical patent/PL2588460T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL11804008T 2010-06-30 2011-06-13 Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych PL2588460T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/826,864 US8815265B2 (en) 2010-06-30 2010-06-30 Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
PCT/US2011/040141 WO2012005872A1 (en) 2010-06-30 2011-06-13 Cosmetic use of n-substituted solfonyloxybenzylamines and related compounds
EP11804008.8A EP2588460B1 (en) 2010-06-30 2011-06-13 Cosmetic use of n-substituted solfonyloxybenzylamines and related compounds

Publications (1)

Publication Number Publication Date
PL2588460T3 true PL2588460T3 (pl) 2017-12-29

Family

ID=45400170

Family Applications (2)

Application Number Title Priority Date Filing Date
PL11804008T PL2588460T3 (pl) 2010-06-30 2011-06-13 Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych
PL17183427T PL3254669T3 (pl) 2010-06-30 2011-06-13 Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17183427T PL3254669T3 (pl) 2010-06-30 2011-06-13 Kosmetyczne zastosowanie N-podstawionych sulfonyloksybenzyloamin i związków powiązanych

Country Status (13)

Country Link
US (2) US8815265B2 (pl)
EP (2) EP2588460B1 (pl)
JP (1) JP6075733B2 (pl)
CN (1) CN102869649B (pl)
AR (1) AR081788A1 (pl)
BR (1) BR112012028648B1 (pl)
CA (1) CA2794129C (pl)
ES (2) ES2643632T3 (pl)
MX (1) MX347848B (pl)
PL (2) PL2588460T3 (pl)
TR (1) TR201910526T4 (pl)
TW (1) TWI552764B (pl)
WO (1) WO2012005872A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106367478A (zh) 2009-12-22 2017-02-01 雅芳产品公司 桩蛋白刺激组合物及其化妆品用途
US20110159125A1 (en) 2009-12-29 2011-06-30 Avon Products, Inc. CGRP Compositions and Uses Thereof
US8815265B2 (en) * 2010-06-30 2014-08-26 Avon Products, Inc. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
EP2588593B1 (en) 2010-06-30 2017-08-23 Avon Products, Inc. Compositions and methods for stimulating magp-1 to improve the appearance of skin
US8455518B2 (en) * 2010-12-28 2013-06-04 Avon Products, Inc. Method of treating skin with microRNA modulators
JP6249777B2 (ja) * 2010-12-30 2017-12-20 エイボン プロダクツ インコーポレーテッド 皮膚におけるダイニンの調節
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
US9345659B2 (en) 2012-12-11 2016-05-24 Avon Products, Inc. Use of melicope extracts to improve conditions caused by excess lipids
TW201422246A (zh) 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節ｗｉｐｉ－１改善皮膚老化外觀之方法
WO2014092686A1 (en) * 2012-12-11 2014-06-19 Avon Products, Inc. Stephanotis jasminoides extracts and methods of use
US9186316B2 (en) 2012-12-11 2015-11-17 Avon Products, Inc. Stephanotis jasminoides extracts and methods of use
WO2014092684A2 (en) * 2012-12-11 2014-06-19 Avon Products, Inc. Use of melicope extracts to improve conditions caused by excess lipids
US20150359731A1 (en) * 2013-03-14 2015-12-17 Avon Products, Inc Phyllanthus acidus extracts and methods of use
CA2960680A1 (en) * 2014-09-12 2016-03-17 Avon Products, Inc. Moldable mascara comprising an opaque wax, a gellant, a particulate, and an oil

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122029A (en) 1977-07-27 1978-10-24 Dow Corning Corporation Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant
US4781917A (en) 1987-06-26 1988-11-01 The Proctor & Gamble Company Antiperspirant gel stick
DE19737327A1 (de) * 1997-08-27 1999-03-04 Haarmann & Reimer Gmbh Hydroxyzimtsäureamide hydroxysubstituierter aromatischer Amine
US6685952B1 (en) 1999-06-25 2004-02-03 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems
GB9918023D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition
US20030059450A1 (en) * 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
WO2003041521A2 (en) 2001-11-09 2003-05-22 Vector Tobacco Inc. Method and composition for mentholation of charcoal filtered cigarettes
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
UA82835C2 (en) 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
US20040105875A1 (en) * 2002-10-03 2004-06-03 L'oreal Composition containing a secondary or tertiary carbonyl amine, method of use thereof, compounds
EP1648403B1 (en) 2003-05-20 2012-08-15 Sederma Slimming cosmetic composition comprising cafestol or kahweol
JP4954450B2 (ja) 2004-06-14 2012-06-13 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス 弾性繊維形成の不全、欠損又は無秩序による病状に対処するための、リシルオキシダーゼのアイソフォームの活性の誘導
JP4527451B2 (ja) 2004-06-14 2010-08-18 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス 弾性繊維の形成を刺激するための、ｌｏｘｌ（リシルオキシダーゼ類似）アイソフォームの合成及び活性の刺激
WO2006043788A1 (en) 2004-10-20 2006-04-27 Doosan Corporation Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine
BRPI0406040B1 (pt) 2004-10-21 2018-09-11 Universidade Federal Do Rio De Janeiro - Ufrj compostos capazes de absorver radiação ultravioleta, composições contendo os mesmos e processos para sua preparação
WO2006091862A2 (en) 2005-02-24 2006-08-31 Kemia, Inc. Cytokine inhibitors and their use in therapy
DE102005018191A1 (de) 2005-04-19 2006-10-26 Grünenthal GmbH Substituierte zyklische Harnstoff-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
WO2006125208A1 (en) 2005-05-19 2006-11-23 Wayne State University Inhibitors of matrix metalloproteinases
JP2007026356A (ja) 2005-07-21 2007-02-01 Sony Corp 情報処理装置、この情報処理装置における処理方法およびその方法をコンピュータに実行させるプログラム
WO2007026356A2 (en) 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
JP5192380B2 (ja) * 2005-09-08 2013-05-08 株式會社アモーレパシフィック 皮膚老化防止用皮膚外用剤組成物
US7060849B1 (en) 2005-09-15 2006-06-13 General Electric Company Method for production of isocyanatosilanes
KR100659138B1 (ko) 2005-09-16 2006-12-19 (주)아모레퍼시픽 유효성분으로 갈로카테킨 갈레이트를 함유하는 보습용피부외용제 조성물
EP1940346A2 (en) 2005-09-30 2008-07-09 The Procter and Gamble Company Composition for regulation of mammalian keratinous tissue
WO2007058990A2 (en) 2005-11-14 2007-05-24 Kemia, Inc. Therapy using cytokine inhibitors
US20100249234A1 (en) 2007-04-10 2010-09-30 Uwm Research Foundation, Inc. Methods of reducing virulence in bacteria
DK2182969T3 (en) 2007-07-31 2017-02-27 Univ Texas Micro-RNA family that modulates fibrosis and its applications
CN101835449A (zh) * 2007-08-31 2010-09-15 Dsmip资产有限公司 4-脒基苄胺用于美容和/或皮肤病学的用途
AU2010234087B2 (en) 2009-04-02 2016-05-12 Merck Patent Gmbh Piperidine and piperazine derivatives as autotaxin inhibitors
JP6059859B2 (ja) 2009-11-16 2017-01-11 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエスＢＡＳＦ Ｂｅａｕｔｙ Ｃａｒｅ Ｓｏｌｕｔｉｏｎｓ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． 弾性繊維の形成を刺激するための、ｌｏｘｌ（リシルオキシダーゼ類似）アイソフォームの合成及び活性の刺激
EP2588593B1 (en) * 2010-06-30 2017-08-23 Avon Products, Inc. Compositions and methods for stimulating magp-1 to improve the appearance of skin
US8815265B2 (en) * 2010-06-30 2014-08-26 Avon Products, Inc. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
US8455518B2 (en) * 2010-12-28 2013-06-04 Avon Products, Inc. Method of treating skin with microRNA modulators
JP6249777B2 (ja) 2010-12-30 2017-12-20 エイボン プロダクツ インコーポレーテッド 皮膚におけるダイニンの調節

Also Published As

Publication number Publication date
ES2643632T3 (es) 2017-11-23
WO2012005872A1 (en) 2012-01-12
CN102869649B (zh) 2016-08-03
US20120004302A1 (en) 2012-01-05
MX347848B (es) 2017-05-16
CN102869649A (zh) 2013-01-09
TR201910526T4 (tr) 2019-08-21
EP3254669A1 (en) 2017-12-13
BR112012028648A2 (pt) 2015-09-15
HK1174628A1 (zh) 2013-06-14
EP2588460B1 (en) 2017-08-09
JP6075733B2 (ja) 2017-02-08
US8815265B2 (en) 2014-08-26
TWI552764B (zh) 2016-10-11
US20140329898A1 (en) 2014-11-06
CA2794129C (en) 2018-05-01
AR081788A1 (es) 2012-10-17
CA2794129A1 (en) 2012-01-12
PL3254669T3 (pl) 2019-11-29
US9409860B2 (en) 2016-08-09
EP3254669B1 (en) 2019-04-17
TW201206487A (en) 2012-02-16
EP2588460A4 (en) 2015-05-06
BR112012028648B1 (pt) 2018-02-06
JP2013533255A (ja) 2013-08-22
MX2012014495A (es) 2013-02-21
ES2737303T3 (es) 2020-01-13
EP2588460A1 (en) 2013-05-08

Similar Documents

Publication Publication Date Title
IL266168A (en) Heteroaryl compounds and methods of their use
EP2588460A4 (en) COSMETIC USE OF N-SUBSTITUTED SULFONYLOXYBENZYLAMINES AND RELATED COMPOUNDS
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
IL247595A0 (en) New modulators and methods of use
SG10202009963PA (en) Melanin modification compositions and methods of use
IL219974A0 (en) Therapeutic compounds and related methods of use
IL226231A0 (en) A formulation of lacosamide that is administered once a day
ZA201301120B (en) Heterocyclic compound and use thereof
SG10201601792UA (en) Novel modulators and methods of use
EP2464227A4 (en) COMPOUNDS AND METHODS OF USE
IL225227A0 (en) Preparations including fulvestrant and methods of use
PL2802325T3 (pl) Związki znieczulające i powiązane sposoby zastosowania
ZA201402758B (en) Brimonidine gel compositions and methods of use
PL2616062T3 (pl) Stosowanie pochodnych pentapiryny jako środków przeciwdrobnoustrojowych i dezynfekujących
GB201011411D0 (en) Therapeutic compounds and their use
ZA201302952B (en) Fungicidal compositions and methods of use
ZA201300012B (en) Synthesis and use of kinase inhibitors
EP2773343A4 (en) COSMETIC USE OF N-HETEROARYLBISAMIDE ANALOGS AND RELATED COMPOUNDS
GB2478317B (en) Herbicidal composition and method of use thereof
EP2680846A4 (en) USE OF N- (4-METHOXYPHENYL) -1-PHENYL-1H-PYRAZOL-3-AMINE AND COMPOUNDS ASSOCIATED THEREWITH
IL225708A0 (en) Methods for the synthesis of scylitol and related compounds
PL2588073T3 (pl) Kompozycja kosmetyczna dla paznokci i zastosowanie pochodnej izosorbidu
EP2649096A4 (en) HEMOGLOBIN COMPOSITIONS AND METHODS OF USE
PL2574343T3 (pl) Kompozycja do nanoszenia na skórę i zastosowanie tej kompozycji
GB201020463D0 (en) Herbicidal compositions and methods of use